| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4215694 | Revue des Maladies Respiratoires Actualités | 2014 | 4 Pages |
Abstract
The rearrangement of ALK mutation is are cent discovery, which is not uncommon, and has a promising targeted therapy: crizotinib, so it seems important to know this disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
M. Emery, N. Girard,